|
CALM1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.199600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.438990E-01 |
| Normal-vs-Stage2 |
7.741200E-01 |
| Normal-vs-Stage3 |
4.329800E-02 |
| Normal-vs-Stage4 |
2.858300E-02 |
| Stage1-vs-Stage2 |
2.227200E-01 |
| Stage1-vs-Stage3 |
4.034200E-01 |
| Stage1-vs-Stage4 |
2.258600E-01 |
| Stage2-vs-Stage3 |
8.143600E-02 |
| Stage2-vs-Stage4 |
5.756500E-02 |
| Stage3-vs-Stage4 |
6.878400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.282400E-02 |
| Normal-vs-AfricanAmerican |
7.389800E-01 |
| Normal-vs-Asian |
9.524200E-01 |
| Caucasian-vs-AfricanAmerican |
3.900600E-01 |
| Caucasian-vs-Asian |
1.800390E-01 |
| AfricanAmerican-vs-Asian |
8.615200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.679900E-02 |
| Normal-vs-Female |
1.180350E-01 |
| Male-vs-Female |
5.927600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.299000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.212200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.583150E-01 |
| Normal-vs-Age(81-100Yrs) |
8.065400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.612000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.715000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.917600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.090400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.971000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.567400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.423990E-02 |
| Classical-VS-Follicular |
8.330800E-01 |
| Classical-VS-Other |
5.041500E-02 |
| Classical-VS-Normal |
2.951800E-01 |
| Tall-VS-Follicular |
3.793800E-02 |
| Tall-VS-Other |
2.288200E-01 |
| Tall-VS-Normal |
3.082600E-03 |
| Follicular-VS-Other |
1.018420E-01 |
| Follicular-VS-Normal |
6.021600E-01 |
| Other-VS-Normal |
2.560500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.912810E-01 |
| Normal-vs-N1 |
5.060100E-03 |
| N0-vs-N1 |
7.022400E-02 |
|
|
